Article
Gene Polymorphisms in the RANKL/RANK/OPG Pathway Are Associated with Type 2 Diabetes Mellitus in Southern Han Chinese Women.
Genetic testing and molecular biomarkers - 1 Jun 2016
Duan Peng, Tu Ping, Si Lian, Hu Wan, Liu Meng, Liu Jia, Xue Yaoming
Abstract excerpt
AIMS: Receptor activator of nuclear factor-kappa B ligand (RANKL), its receptor activator of nuclear factor-kappa B (RANK), and decoy receptor osteoprotegerin (OPG) are three major proteins of the RANKL/RANK/OPG signaling pathway encoded by TNFSF11, TNFRSF11A, and TNFRSF11B, respectively. This pathway plays a critical role in bone remodeling and may have a role in the pathogenesis of type 2 diabetes mellitus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
